Загрузка...
Real-Life Effectiveness and Tolerability of Perampanel in Pediatric Patients Aged 4 Years or Older with Epilepsy: A Korean National Multicenter Study
BACKGROUND AND PURPOSE: The US Food and Drug Administration approval for perampanel has only recently been expanded to patients as young as 4 years, and so there have been few real-life studies of the effects of perampanel in pediatric patients. The aim of this study was to determine the long-term e...
Сохранить в:
| Опубликовано в: : | J Clin Neurol |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Korean Neurological Association
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6974830/ https://ncbi.nlm.nih.gov/pubmed/31942758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3988/jcn.2020.16.1.53 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|